Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IST:ANGEN)

Turkey · Delayed Price · Currency is TRY

8.77

-0.04 (-0.45%)

At close: Sep 4, 2026

Market Cap	1.93B -31.2%
Revenue (ttm)	747.38M -3.5%
Net Income	-258.43M
EPS	-1.17
Shares Out	220.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.60 (6.69%)
Ex-Dividend Date	n/a

Volume	1,298,328
Open	8.94
Previous Close	8.81
Day's Range	8.70 - 8.94
52-Week Range	8.70 - 16.00
Beta	0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About IST:ANGEN

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, rapid antigen test kits, and automated nucleic acid (NA) extraction instruments in Turkey. It offers microbiology, genetic disorder, multiplex panel, drug resistance sequencing, food testing kits, as well as sample collection and transport; and full automation, manual magnetic bead NA extraction, and automated NA extraction instrument kits. The compan... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2010

Employees 259

Stock Exchange Istanbul Stock Exchange

Ticker Symbol ANGEN

Full Company Profile

Financial Performance

In 2025, IST:ANGEN's revenue was 739.63 million, an increase of 6.65% compared to the previous year's 693.51 million. Losses were -312.73 million, 9.16% more than in 2024.

Financial Statements